Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 168

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Characterization of a Cdc42 Protein Inhibitor and Its Use as a Molecular Probe

Open access
Hong, Lin, Kenney, S.Ray, Phillips, Genevieve K., Simpson, Denise, Schroeder, Chad E., Nöth, Julica, Romero, Elsa, Swanson, Scarlett, Waller, Anna, Strouse, J.Jacob, Carter, Mark, Chigaev, Alexandre, Ursu, Oleg, Oprea, Tudor, Hjelle, Brian, Golden, Jennifer E., Aubé, Jeffrey, Hudson, Laurie G., Buranda, Tione, Sklar, Larry A., Wandinger-Ness, Angela · 2013 · Journal of Biological Chemistry

Abstract

Cdc42 plays important roles in cytoskeleton organization, cell cycle progression, signal transduction, and vesicle trafficking. Overactive Cdc42 has been implicated in the pathology of cancers, immune diseases, and neuronal disorders. Therefore, Cdc42 inhibitors would be useful in probing molecular pathways and could have therapeutic potential. Previous inhibitors have lacked selectivity and trended toward toxicity. We report here the characterization of a Cdc42-selective guanine nucleotide binding lead inhibitor that was identified by high throughput screening. A second active analog was identified via structure-activity relationship studies. The compounds demonstrated excellent selectivity with no inhibition toward Rho and Rac in the same GTPase family. Biochemical characterization showed that the compounds act as noncompetitive allosteric inhibitors. When tested in cellular assays, the lead compound inhibited Cdc42-related filopodia formation and cell migration. The lead compound was also used to clarify the involvement of Cdc42 in the Sin Nombre virus internalization and the signaling pathway of integrin VLA-4. Together, these data present the characterization of a novel Cdc42-selective allosteric inhibitor and a related analog, the use of which will facilitate drug development targeting Cdc42-related diseases and molecular pathway studies that involve GTPases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m112.435941

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 168

Metadata

Authors
Hong, L., Kenney, S. R., Phillips, G. K., Simpson, D., Schroeder, C. E., Nöth, J., Romero, E., Swanson, S., Waller, A., Strouse, J. J., Carter, M., Chigaev, A., Ursu, O., Oprea, T., Hjelle, B., Golden, J. E., Aubé, J., Hudson, L. G., Buranda, T., Sklar, L. A., & Wandinger-Ness, A.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2013-03
Volume
288
Issue
12
Pages
8531-8543
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2153660769
Cited by
168
References
4
FWCI
5.51
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization of a Cdc42 Protein Inhibitor and Its Use as a Molecular Probe. https://app.cochat.ai/papers/10.1074/jbc.m112.435941
The paper
Hong, L., Kenney, S. R., Phillips, G. K., Simpson, D., Schroeder, C. E., Nöth, J., Romero, E., Swanson, S., Waller, A., Strouse, J. J., Carter, M., Chigaev, A., Ursu, O., Oprea, T., Hjelle, B., Golden, J. E., Aubé, J., Hudson, L. G., Buranda, T., . . . Wandinger-Ness, A. (2013). Characterization of a Cdc42 Protein Inhibitor and Its Use as a Molecular Probe. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m112.435941

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.